RxDoctor Payments Data

James Guarrera

Transplant Surgery · Newark, NJNPI 1417998782

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $945,086 of the $1,021,884 with a category attached, or 92.5%. Organ Recovery Systems, Inc. accounts for 98.8% of it on its own, with 9 other manufacturers making up the rest.

$1,021,884in general payments, 2019–2025

Across 166 payments — averaging $6155.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organ Recovery Systems, Inc.$1M
  • CSL Behring$7K
  • Novartis$3K
  • Transmedics, Inc.$1K
  • Dilon Technologies, Inc.$669
  • Medistim USA, Inc.$273
  • plus $356 from 4 others
$2,516,547in research payments, 2019–2025

Across 98 payments — averaging $25,679 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Organ Recovery Systems, Inc.$2.5M

What the payments were for

  • Consulting fees$945,08692%
  • Speaking & faculty fees$6,6951%
  • Travel & lodging$53,5085%
  • Food & beverage$16,5952%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few transplant surgery providers in New Jerseyto place this figure against a meaningful peer group, so we don't.

Other transplant surgery in Newark

See the full list for New Jersey

Where these figures come from

Is this you, or does something look wrong? →